Evidence map›Paper›PMID 33608919›Full record

ArticleAllergy2021

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort.

Nikolaos G Papadopoulos, Alexander G Mathioudakis, Adnan Custovic, Antoine Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Xepapadaki, Rola Abou-Taam, Ioana Agache, Jose A Castro-Rodriguez and 33 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Early Origins of Asthma and Allergies: Clues From Studies in China.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Review
  8. Review
  9. The COVID-19 pandemic and asthma management: a family caregiver perspective.The Journal of asthma : official journal of the Association for the Care of Asthma · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Pediatric asthma comorbidities: Global impact and unmet needs.The World Allergy Organization journal · 2024
    Review
  17. Article
  18. Article
  19. Prediction of Asthma Exacerbations in Children.Journal of personalized medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 17 countries.

Nikolaos G PapadopoulosDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.ORCID 0000-0002-4448-3468
Alexander G MathioudakisDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.ORCID 0000-0002-4675-9616
Adnan CustovicImperial College London, London, UK.
Antoine DeschildreINSERM Unit 1019, CNRS UMR 8204, Center for infection and immunity of Lille, Institut Pasteur de Lille, Univ. Lille, Lille cedex, France.ORCID 0000-0003-2006-7221
Wanda PhipatanakulDepartment of Allergy and Immunology, Boston Children's Hospital, Boston, MA, USA.
Gary WongDepartment of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong.ORCID 0000-0001-5939-812X
Paraskevi XepapadakiAllergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0001-9204-1923
Rola Abou-TaamPediatric Pulmonology and Allergy DepartmentHôpital Necker-Enfants Malades, Paris, France.
Ioana AgacheAllergy & Clinical Immunology, Transylvania University, Brasov, Romania.ORCID 0000-0001-7994-364X
Jose A Castro-RodriguezDepartment of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Zhimin ChenDepartment of Pulmonology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.ORCID 0000-0003-4267-9579
Pierrick CrosDepartment of Pediatrics, University Hospital Morvan, Brest, France.
Jean-Christophe DubusCentre de Ressources et de Compétences pour la Mucoviscidose Pneumo-Allergologie, Ventilation, Maladies RespiratoiresRares de l'Enfant CHU Timone-Enfants, Marseille, France.
Zeinab Awad El-SayedPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Rasha El-OwaidyPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.ORCID 0000-0002-5609-4160
Wojciech FeleszkoDepartment of Pediatric Pneumonology and Allergy, The Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6613-2012
Vincenzo FierroAllergy Department, Bambino Gesù Children's Hospital IRCCS, Roma, Italy.
Alessandro FiocchiAllergy Department, Bambino Gesù Children's Hospital IRCCS, Roma, Italy.ORCID 0000-0002-2549-0523
Luis Garcia-MarcosPediatric Respiratory and Allergy Units, "Virgen de la Arrixaca" Children's University Clinical Hospital, University of Murcia, Murcia, Spain.
Anne GohDepartment of Internal Medicine, Rush Medical College, Chicago.
Elham M HossnyPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Yunuen R Huerta VillalobosHospital General Regional 1 "Dr. Carlos Mac Gregor Sánchez Navarro" IMSS, Mexico, Mexico.
Tuomas JarttiDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland.
Pascal Le RouxDepartment of Pediatrics, Groupe Hospitalier Le Havre, Le Havre, France.
Julia LevinaPediatric and Child Health Research Institute of the Central Clinical Hospital of the Russian Academy of Sciences, Moskva, Russia.
Aida Inés López GarcíaAllergy and Clinical Immunology Service of the University Hospital of Puebla, Puebla, Mexico.
Ángel Mazón RamosPediatric Pulmonology & Allergy Unit Children's Hospital la Fe, Valencia, Spain.
Mário Morais-AlmeidaAllergy Center, CUF Descobertas Hospital, Lisbon, Portugal.ORCID 0000-0003-1837-2980
Clare MurrayDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.
Karthik NagarajuVN Allergy & Asthma Research Centre, Chennai, India.
Major K NagarajuDepartment of Allergy & Clinical Immunology, Saveetha Medical College, Chennai, India.
Elsy Maureen Navarrete RodriguezPediatric Allergy and Clinical Immunology Service, Hospital Infantil, til de Mexico Federico Gómez, Mexico City, Mexico.
Leyla Namazova-BaranovaPediatric and Child Health Research Institute of the Central Clinical Hospital of the Russian Academy of Sciences, Moskva, Russia.
Antonio Nieto GarciaPediatric Pulmonology & Allergy Unit Children's Hospital la Fe, Valencia, Spain.
Cesar Fireth Pozo BeltránTeaching and Research Department and Paediatric Allergy Department, Hospital with Specialties Juan María de Salvatierra, La Paz, Mexico.
Thanaporn RatchataswanDepartment of Allergy and Immunology, Boston Children's Hospital, Boston, MA, USA.
Daniela Rivero YeverinoAllergy and Clinical Immunology Department, Hospital Universitario de Puebla, Puebla, Mexico.
Eréndira Rodríguez ZagalHospital General Regional 1 "Dr. Carlos Mac Gregor Sánchez Navarro" IMSS, Mexico, Mexico.
Cyril E SchweitzerCHRU de Nancy, Hôpitald'Enfants, Vandoeuvre, France.
Marleena TulkkiDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
Katarzyna WasilczukDepartment of Pediatric Pneumonology and Allergy, The Medical University of Warsaw, Warsaw, Poland.
Dan XuDepartment of Pulmonology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
PeARL collaborators, on behalf of the PeARL Think Tank
Ain Shams University Hospital · EGBambino Gesù Children's Hospital · ITBoston Children's Hospital · USChildren's Hospital of Zhejiang University · CNHospital Infantil de México Federico Gómez · MXMedical University of Warsaw · PLNational and Kapodistrian University of Athens · GRRussian Academy of Sciences · RUUniversidad de Puebla · MXCentre Hospitalier Régional Universitaire de Brest · FRCentre National de la Recherche Scientifique · FRChinese University of Hong Kong · HKCUF Porto Hospital · PTGroupe Hospitalier du Havre · FRHôpital d'Enfants · FRHôpital Necker-Enfants Malades · FRImperial College London · GBInstituto Murciano de Investigación Biosanitaria · ESInstituto Universitario Puebla · MXManchester Academic Health Science Centre · GB

Funding

Medical Research Council MR/S025340/1
6 · The paper itself

Abstract

backgroundThe interplay between COVID-19 pandemic and asthma in children is still unclear. We evaluated the impact of COVID-19 pandemic on childhood asthma outcomes.

methodsThe PeARL multinational cohort included 1,054 children with asthma and 505 non-asthmatic children aged between 4 and 18 years from 25 pediatric departments, from 15 countries globally. We compared the frequency of acute respiratory and febrile presentations during the first wave of the COVID-19 pandemic between groups and with data available from the previous year. In children with asthma, we also compared current and historical disease control.

resultsDuring the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks, and hospitalizations due to asthma, in comparison with the preceding year. Sixty-six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimal clinically important difference. Pre-bronchodilatation FEV

conclusionChildhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.

Indexed as

AsthmaCOVID-19AdolescentChildChild, PreschoolHospitalizationHumansPandemicsSARS-CoV-2childhood asthmacoronavirusCOVID-19

Identifiers

PMID33608919
PMCPMC8013557
OpenAlexW3133299179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.